Latuda (lurasidone) is a prescription drug that’s prescribed to treat schizophrenia and bipolar disorder. Latuda comes as a tablet that you take by mouth. Latuda is prescribed to adults, adolescents, ...

As with other drugs, Latuda (lurasidone) can cause side effects, such as restlessness, nausea, and weight gain. If side effects of Latuda become difficult to tolerate, talk with your doctor or ...

Latuda's (lurasidone HCI; Sunovion) expanded indication has been approved for pediatric patients aged 10 to 17 years who have major depressive episodes associated with bipolar I disorder. The Food and ...

MARLBOROUGH, Mass. -- Sunovion Pharmaceuticals Inc. (Sunovion) today announced that Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent indicated for the treatment of adult ...

Sunovion announced that the Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Latuda (lurasidone HCl) for the treatment of schizophrenia in adolescents ...

Please provide your email address to receive an email when new articles are posted on . To assess efficacy and safety of Latuda (lurasidone, Sunovion Pharmaceuticals) for schizophrenia in adolescents, ...

Please provide your email address to receive an email when new articles are posted on . Sunovion recently announced that the FDA approved a supplemental New Drug Application for Latuda for the ...

Mark Iwicki’s top priority is driving the success of Latuda, an atypical antipsychotic for adults with schizophrenia. “It’s the most important product and business we have for the next couple of years ...

If you have schizophrenia or bipolar I disorder, your doctor may prescribe a daily pill called lurasidone (Latuda). It’s an atypical or second-generation antipsychotic (SGA). Like other SGAs, ...

The Food and Drug Administration approved a new use for Sunovion Pharmaceuticals’ Latuda to treat schizophrenia in kids aged 13 to 17 years. The drug was first approved in 2010 as a treatment for ...

Sunovion's launch web site for its new schizophrenia drug Latuda uses an image of a man literally cracking up into pieces as his mother looks on adoringly. The bizarre image shows a smiling ...

Sunovion Pharmaceuticals' new antipsychotic drug has hit drugstores, aiming to capture a share of the already crowded market. It's a branded drug in a class that now includes one leading ...